SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
PETS

Petmed Express Inc (NASDAQ:PETS)

US · Delayed Price · Currency is USD
Consumer Cyclical · Specialty Retail
$0.87-$0.06 (-6.35%)
 
Market cap
$19.2M
Insider Score
Health Score
Analyst consensus
Listed since
Apr 26, 1999
Market Cap$19.25M-46.2%
Revenue (ttm)$160.26M-17.8%
Net Income-$27.19M+50.6%
EPS-$1.28+51.8%
Shares Out22.23M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend DateAug 11, 2023
Volume69,652
Open$0.86
Previous Close$0.92
Day's Range$0.86 - $0.91
52-Week Range$0.85 - $4.10
Beta0.83
AnalystsHold
Price Target$1.40(+61.72%)
Earnings DateFeb 4, 2027
-5.88% (1D)
No price history available.

About PETS

PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.

Address
420 South Congress Avenue, Delray Beach, FL, 33445, US
Market Cap
19 million
Employees
189
Industrial Classification
Specialty Retail

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$43.75K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Sell
0 Buy0 Hold1 SellAvg target $1.40 (+56.7%)

1 firm rating PETS in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Weak
From PETS’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-6.35%
5 Days
-10.75%
1 Month
-27.86%
6 Months
-61.18%
1 Year
-46.23%

$PETS stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in PETS holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by PETS's directors and management

Net Shares Purchased by Insiders−30k−15k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

PETS Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New PETS patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to PETS from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in PETS

PAWZProShares Pet Care ETF$1.69M
SLYSPDR S&P 600 Small Cap ETF$725.09K
VTIVanguard Morningstar Total Stock Market ETF$565.27K
VXFVanguard Extended Market ETF$251.19K
BSVOEA Bridgeway Omni Small-Cap Value ETF$90.00K
IWCiShares Micro-Cap ETF$43.27K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from PETS’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
60
News & Sentiment
20% of score
35

News check: Q2 earnings miss on revenue with reported loss, partially offset by new CEO leadership and retail partnership expansion.

Recent Insider Activity

Buys
1
Sells
0
Buy Value
$43.75K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

PAWZProShares Pet Care ETF5.01%
PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF0.20%
STSBiShares Factors US Small Blend Style ETF0.10%
DMRSDeltaShares S&P 600 Managed Risk ETF0.08%
SLYSPDR S&P 600 Small Cap ETF0.04%
BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF0.01%
BSVOEA Bridgeway Omni Small-Cap Value ETF0.00%

Weight is the stock’s share of each fund’s holdings.